Characteristic, n (%) or median [Q1, Q3] | GRT-RD n = 39 | RRD n = 1661 | p-value |
---|---|---|---|
Preoperative characteristics | |||
Age, years | 59.0 [52.0, 62.0] | 62.0 [56.0, 69.0] | 0.003 |
Male sex | 29 (74%) | 1049 (63%) | 0.15 |
Duration of symptoms, days | 7 [5, 13] | 7 [4, 15] | 0.73 |
Asymptomatic patients | 0 (0%) | 21 (1%) | 1.00 |
Baseline visual acuity, logMAR | 0.30 [0.10, 2.30] | 0.54 [0.10, 2.30] | 0.14 |
Snellen | 20/40 | 20/70 | |
Affected eye (left) | 21 (54%) | 805 (49%) | 0.51 |
Myopia, > 4 diopters | 7 (18%) | 352/1620 (22%) | 0.57 |
Lens status | 0.30 | ||
Aphakic | 0 (0%) | 11 (0.7%) | |
Phakic | 26 (67%) | 907 (55%) | |
Pseudophakic | 13 (33%) | 743 (45%) | |
Macula status | 0.07 | ||
On | 21 (54%) | 595 (36%) | |
Off | 15 (38%) | 884 (53%) | |
Split | 3 (8%) | 182 (11%) | |
Number of quadrants affected | 2.0 [2.0, 3.0] | 2.0 [2.0, 3.0] | 0.96 |
Intraoperative management | |||
Primary surgery type | 0.07 | ||
SB, n (%) | 0 (0%) | 113 (7%) | |
PPV, n (%) | 16 (41%) | 827 (50%) | |
PPV-SB, n (%) | 23 (59%) | 721 (43%) | |
Primary surgery tamponade agent | < 0.001 | ||
None, n (%) | 0 (0%) | 30 (2%) | |
Air, n (%) | 0 (0%) | 9 (1%) | |
SF6, n (%) | 10 (26%) | 1311 (79%) | |
C3F8, n (%) | 28 (72%) | 291 (18%) | |
Silicone oil, n (%) | 1 (3%) | 20 (1%) | |
Postoperative outcomes | |||
Recurrence of retinal detachment | 7 (18%) | 166 (10%) | 0.10 |
Visual acuity at 3 months, logMAR | 0.30 [0.18, 0.65] | 0.30 [0.10, 0.54] | 0.13 |
Snellen | 20/40 | 20/40 | |
Final visual acuity, logMAR | 0.30 [0.10, 0.30] | 0.18 [0.10, 0.40] | 0.91 |
Snellen | 20/40 | 20/30 | |
Follow-up time, months | 17.0 [4.0, 28.0] | 11.0 [3.0, 25.0] | 0.05 |
Cataract development* | 19/26 (73%) | 687/907 (76%) | 0.75 |